These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Uremic escape of renal allograft rejection. van Schilfgaarde R, van Breda Vriesman PJ. Neth J Surg; 1981 Oct; 33(4):173-80. PubMed ID: 7029351 [Abstract] [Full Text] [Related]
3. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes. Majoor GD, Van Breda Vriesman PJ. Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632 [Abstract] [Full Text] [Related]
4. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions. Jaskłowska-Englisz M, Olszewski WL, Maksymowicz M, Ziółkowska A. Ann Transplant; 1998 Feb; 3(1):28-33. PubMed ID: 9869895 [Abstract] [Full Text] [Related]
6. Influence of recirculating lymphocytes on the rejection of first-set rat organ allografts. van Schilfgaarde R, Hermans P, van Breda Vriesman PJ. Transplant Proc; 1979 Jun 15; 11(2):1485-8. PubMed ID: 38543 [No Abstract] [Full Text] [Related]
7. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. I. Specific prolongation of donor grafts and suppressor factor in the serum. Yoshimura N, Matsui S, Hamashima T, Lee CJ, Ohsaka Y, Oka T. Transplantation; 1990 Jan 15; 49(1):167-71. PubMed ID: 2301007 [Abstract] [Full Text] [Related]
8. Long-term survival of cardiac allografts in lethally irradiated rats repopulated with host-type hemopoietic cells. Dittmer J, Bennett M. Transplantation; 1975 Apr 15; 19(4):295-301. PubMed ID: 239473 [Abstract] [Full Text] [Related]
9. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Ichikawa N, Demetris AJ, Starzl TE, Ye Q, Okuda T, Chun HJ, Liu K, Kim YM, Murase N. Liver Transpl; 2000 Nov 15; 6(6):686-702. PubMed ID: 11084053 [Abstract] [Full Text] [Related]
10. The role of antibody in rat renal allograft rejection. I. Absence of antibody to erythrocyte-associated antigens is associated with enhanced renal allograft survival. Majoor GD, van de Gaar MJ, Vlek LF, van Breda Vriesman PJ. Transplantation; 1981 May 15; 31(5):369-75. PubMed ID: 7015624 [Abstract] [Full Text] [Related]
11. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Murase N, Ye Q, Nalesnik MA, Demetris AJ, Abu-Elmagd K, Reyes J, Ichikawa N, Okuda T, Fung JJ, Starzl TE. Transplantation; 2000 Dec 15; 70(11):1632-41. PubMed ID: 11152226 [Abstract] [Full Text] [Related]
12. Restoration of allograft responsiveness in B rats. IV. The divergent migratory behavior of lymphocyte populations mediating cardiac allograft rejection. Kupiec-Weglinski JW, Lear PA, Heidecke CD, Araneda D, Tilney NL. Cell Immunol; 1984 May 15; 85(2):459-76. PubMed ID: 6424953 [Abstract] [Full Text] [Related]
13. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Binder J, Lehmann M, Graser E, Hancock WW, Watschinger B, Onodera K, Sayegh MH, Volk HD, Kupiec-Weglinski JW. Transplantation; 1996 Mar 15; 61(5):804-11. PubMed ID: 8607187 [Abstract] [Full Text] [Related]
14. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin. Stepkowski SM, Chen HF, Wang ME, Daloze P, Kahan BD. Transplantation; 1992 Feb 15; 53(2):258-64. PubMed ID: 1738917 [Abstract] [Full Text] [Related]
15. Graft-versus-host reactivity and renal allograft survival in rats given allogeneic spleen cells or spleen allografts. Silber SJ, Miller JF, Morris PJ. Transplantation; 1976 Aug 15; 22(2):160-6. PubMed ID: 9713 [Abstract] [Full Text] [Related]
16. [Effects of portal venous administration with allogenic cells on renal allograft survival in the rat]. Hamashima T, Yoshimura N, Matsui S, Lee CJ, Oka T. Nihon Geka Gakkai Zasshi; 1989 Oct 15; 90(10):1752-7. PubMed ID: 2480516 [Abstract] [Full Text] [Related]
17. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB. Transplantation; 1993 May 15; 55(5):1112-8. PubMed ID: 8497891 [Abstract] [Full Text] [Related]
18. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells. Nakao A, Nalesnik MA, Ishikawa T, Azhipa O, Demetris AJ, Murase N. Transplantation; 2003 May 15; 75(9):1575-81. PubMed ID: 12792518 [Abstract] [Full Text] [Related]
19. Importance of T cells to accelerated rejection and acceptance of renal allografts in sensitized rat recipients. Heidecke CD, Zantl N, Maier S, Sewczik T, Westerholt S, Jakobs F, Westerholt A, Hancock WW, Kupiec-Weglinski JW. Transplantation; 1998 Nov 27; 66(10):1354-61. PubMed ID: 9846522 [Abstract] [Full Text] [Related]
20. Small bowel transplantation in the rat: impact of various immunosuppressive regimens on graft-versus-host reaction. Oberhuber G, Schmid T, Erdkönig R, Thaler W, Ofner D, Köröszi G, Klima G, Margreiter R. Eur Surg Res; 1991 Nov 27; 23(3-4):206-13. PubMed ID: 1782966 [Abstract] [Full Text] [Related] Page: [Next] [New Search]